Ligand Pharmaceuticals Inc. (LGND) on GreekSoup https://greeksoup.ai/stocks/us/lgnd/ Every dated entry in the public record on Ligand Pharmaceuticals Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Mon, 12 Oct 2026 00:00:00 +0000 Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 833 shares at $302.51 on 2 October 2026, $251,991https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-10-06:e628efc8aaTue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 1,976 shares at $303.54 on 2 October 2026, $599,804https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-10-06:256b7e0ba6Tue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 1,535 shares at $304.52 on 2 October 2026, $467,431https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-10-06:766d968e51Tue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 404 shares at $306.18 on 2 October 2026, $123,698https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-10-06:3035bbcc57Tue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 235 shares at $307.19 on 2 October 2026, $72,190https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-10-06:4c24ed55eeTue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 17 shares at $307.74 on 2 October 2026, $5,232https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-10-06:c381ec683cTue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: short interest 2,677,998 shares at the 30 September 2026 settlement, 8.73 days to coverhttps://greeksoup.ai/stocks/us/lgnd/short-interest/us:LGND:short-interest:2026-09-30:d9822ad75cWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc. filed 8-K: regulation fd disclosure, other eventshttps://greeksoup.ai/stocks/us/lgnd/filings/us:LGND:filing:2026-09-24:e33db3d1efThu, 24 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc. filed 8-K: regulation fd disclosurehttps://greeksoup.ai/stocks/us/lgnd/filings/us:LGND:filing:2026-09-22:0404bf254cTue, 22 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: short interest 2,632,434 shares at the 15 September 2026 settlement, 13.53 days to coverhttps://greeksoup.ai/stocks/us/lgnd/short-interest/us:LGND:short-interest:2026-09-15:c2a7d6069bTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Zimmermann Martine (Director) sold 1,200 shares at $285.00 on 10 September 2026, $342,000https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-09-14:1d09c2f918Mon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Form 144, MARTINE ZIMMERMANN plans to sell 1,200 shares worth $342,000 around 10 September 2026https://greeksoup.ai/stocks/us/lgnd/planned-sales/us:LGND:planned-sale:2026-09-10:1d70032db4Thu, 10 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 300 shares at $283.99 on 3 September 2026, $85,196https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-09-08:40176e33a0Tue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 1,800 shares at $285.17 on 3 September 2026, $513,301https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-09-08:61f8d04d92Tue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 2,115 shares at $286.36 on 3 September 2026, $605,649https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-09-08:ad771d6d29Tue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 385 shares at $287.53 on 3 September 2026, $110,697https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-09-08:a94e0f6f54Tue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 400 shares at $288.98 on 3 September 2026, $115,592https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-09-08:a8e2ac59c7Tue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Form 144, ANDREW REARDON plans to sell 15,000 shares worth $4.3 million around 3 September 2026https://greeksoup.ai/stocks/us/lgnd/planned-sales/us:LGND:planned-sale:2026-09-03:3280acdceeThu, 03 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc. filed 8-K/A: 8-k/ahttps://greeksoup.ai/stocks/us/lgnd/filings/us:LGND:filing:2026-09-02:fbdba272c8Wed, 02 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: short interest 2,480,981 shares at the 31 August 2026 settlement, 14.12 days to coverhttps://greeksoup.ai/stocks/us/lgnd/short-interest/us:LGND:short-interest:2026-08-31:866d384bd6Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Espinoza Octavio (Chief Financial Officer) sold 31,641 shares at $292.06 on 12 August 2026, $9.2 millionhttps://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-08-14:f8c24d12e2Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Haas Jason (Director) sold 7,138 shares at $292.81 on 12 August 2026, $2.1 millionhttps://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-08-14:3180327953Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: short interest 2,448,076 shares at the 14 August 2026 settlement, 8.76 days to coverhttps://greeksoup.ai/stocks/us/lgnd/short-interest/us:LGND:short-interest:2026-08-14:1b397d653bFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Schedule 13G filed by Invesco Ltd., 6.1% of the classhttps://greeksoup.ai/stocks/us/lgnd/holders/us:LGND:schedule-13:2026-08-13:bf7e9483d4Thu, 13 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Form 144, Jason Haas plans to sell 7,138 shares worth $2.1 million around 12 August 2026https://greeksoup.ai/stocks/us/lgnd/planned-sales/us:LGND:planned-sale:2026-08-12:71615def63Wed, 12 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Form 144, OCTAVIO ESPINOZA plans to sell 31,641 shares worth $9.1 million around 12 August 2026https://greeksoup.ai/stocks/us/lgnd/planned-sales/us:LGND:planned-sale:2026-08-12:5dfb72f0e7Wed, 12 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc. Q2 FY2026 results: revenue $64 million, net income $49 millionhttps://greeksoup.ai/stocks/us/lgnd/results/fy2026-q2/us:LGND:result:2026-08-07:b2f7dab807Fri, 07 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/lgnd/filings/us:LGND:filing:2026-08-07:ce888fe4f3Fri, 07 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/lgnd/filings/us:LGND:filing:2026-08-06:51ccd897b3Thu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 105 shares at $284.14 on 3 August 2026, $29,834https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-08-04:4c79d5bd57Tue, 04 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 33 shares at $284.55 on 3 August 2026, $9,390https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-08-04:edaeb34f7eTue, 04 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 157 shares at $285.74 on 3 August 2026, $44,861https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-08-04:521b65b43aTue, 04 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 1,032 shares at $286.80 on 3 August 2026, $295,974https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-08-04:94efefd22cTue, 04 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 1,214 shares at $287.77 on 3 August 2026, $349,357https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-08-04:57d9f43185Tue, 04 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 356 shares at $288.75 on 3 August 2026, $102,795https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-08-04:28edffacdaTue, 04 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 503 shares at $289.80 on 3 August 2026, $145,771https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-08-04:3fac76f4cdTue, 04 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 200 shares at $290.60 on 3 August 2026, $58,120https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-08-04:7b9824a317Tue, 04 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 991 shares at $291.71 on 3 August 2026, $289,086https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-08-04:f54e35f8ccTue, 04 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: Reardon Andrew (CLO & Secretary) sold 409 shares at $292.82 on 3 August 2026, $119,763https://greeksoup.ai/stocks/us/lgnd/insiders/us:LGND:insider:2026-08-04:2237c96992Tue, 04 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: short interest 2,169,585 shares at the 31 July 2026 settlement, 7.36 days to coverhttps://greeksoup.ai/stocks/us/lgnd/short-interest/us:LGND:short-interest:2026-07-31:bf2dad559dFri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc. filed S-8: s-8https://greeksoup.ai/stocks/us/lgnd/filings/us:LGND:filing:2026-07-22:dad62b9668Wed, 22 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc.: short interest 1,918,207 shares at the 15 July 2026 settlement, 4.99 days to coverhttps://greeksoup.ai/stocks/us/lgnd/short-interest/us:LGND:short-interest:2026-07-15:2b65196a0aWed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Ligand Pharmaceuticals Inc. filed 8-K: material agreement, acquisition or disposition completed, new financial obligation, regulation fd disclosurehttps://greeksoup.ai/stocks/us/lgnd/filings/us:LGND:filing:2026-07-14:d7b1aed9b5Tue, 14 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>